21 CFR 520.1367
§ 520.1367 Meloxicam.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.1367, § 520.1367 Meloxicam, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87222
- Permanent ID
ys:prov:87222@1- SHA-256
0f9dbe2c5f02f68ef8a3295df585cf7e51af229ba414a9faf55c038e8ff1d97d
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications—(1) Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam.
(2) Each milliliter of suspension contains 1.5 mg meloxicam.
(b) Sponsors. See sponsors in § 510.600(c) of this chapter for uses as in paragraph (c) of this section:
(1) Nos. 000010 and 069043 for use of the products described in paragraph (a) of this section; and
(2) Nos. 013744, 055529, and 086101 for use of the product described in paragraph (a)(2) of this section.
(c) Conditions of use in dogs—(1) Amount. Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.
(2) Indications for use. For the control of pain and inflammation associated with osteoarthritis.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.